2 months ago
GILD
AnalystsBrian AbrahamsBrian Abrahams's Stock Forecasts
AnalystsBrian Abrahams
Analyst Ranking
Bottom 46%
#2789 out of 5072 analysts
Average Return
+0.01%
Win Rate
44%121 out of 275
Risk vs Reward
Poor
Good
Brian Abrahams's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +558.80% | $2.67 | $17.59 | 2022-05-11 - 2023-05-11 | Buy |
Pliant Therapeutics IncPLRX | +382.01% | $4.67 | $22.51 | 2022-05-09 - 2023-05-09 | Buy |
Ambrx Biopharma IncAMAM | +233.33% | $8.40 | $28.00 | 2023-10-22 - 2024-03-06 | Buy |
Mind Medicine IncMNMD | +222.26% | $3.01 | $9.70 | 2023-03-09 - 2024-03-08 | Buy |
Ambrx Biopharma IncAMAM | +210.77% | $9.01 | $28.00 | 2023-11-13 - 2024-03-06 | Buy |
Brian Abrahams Analyst Color
Get additional color on Brian Abrahams's coverage of popular stocks
a year ago
APLT
2 years ago
MNMD
Brian Abrahams's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Galapagos NvGLPG | 11 | Hold | $28.00 | -12.14% | Maintains | a day ago |
Moonlake ImmunotherapeuticsMLTX | 3 | Hold | $10.00 | +4.17% | Downgrades | 24 days ago |
Apogee Therapeutics IncAPGE | 1 | Buy | $60.00 | +12.19% | Initiates Coverage On | a month ago |
Incyte CorpINCY | 22 | Hold | $81.00 | -8.02% | Maintains | a month ago |
Atyr Pharma IncATYR | 1 | Hold | $1.50 | +55.28% | Downgrades | a month ago |
Kymera Therapeutics IncKYMR | 1 | Buy | $70.00 | +25.45% | Initiates Coverage On | a month ago |
Neurocrine Biosciences IncNBIX | 21 | Buy | $149.00 | +5.32% | Maintains | 2 months ago |
Sionna Therapeutics IncSION | 1 | Hold | $22.00 | -43.44% | Initiates Coverage On | 2 months ago |
Xenon Pharmaceuticals IncXENE | 19 | Buy | $55.00 | +30.39% | Reiterates | 2 months ago |
Aardvark Therapeutics IncAARD | 4 | Buy | $19.00 | +73.20% | Maintains | 2 months ago |
Ptc Therapeutics IncPTCT | 17 | Buy | $63.00 | -5.29% | Maintains | 2 months ago |
Gilead Sciences IncGILD | 30 | Hold | $98.00 | -19.32% | Maintains | 2 months ago |
89bio IncETNB | 14 | Hold | $11.00 | -25.68% | Maintains | 2 months ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $40.00 | +87.00% | Maintains | 3 months ago |
Vertex Pharmaceuticals IncVRTX | 54 | Hold | $405.00 | -5.03% | Maintains | 3 months ago |
Prothena Corp Public Ltd CoPRTA | 11 | Hold | $10.00 | +1.21% | Maintains | 3 months ago |
Regeneron Pharmaceuticals IncREGN | 33 | Hold | $695.00 | +18.86% | Maintains | 3 months ago |
Biogen IncBIIB | 38 | Buy | $219.00 | +48.25% | Maintains | 3 months ago |
Sarepta Therapeutics IncSRPT | 31 | Hold | $23.00 | +2.36% | Maintains | 3 months ago |
Biocryst Pharmaceuticals IncBCRX | 15 | Buy | $13.00 | +83.62% | Reiterates | 4 months ago |
Cidara Therapeutics IncCDTX | 1 | Buy | $75.00 | -24.49% | Maintains | 4 months ago |
Contineum Therapeutics IncCTNM | 5 | Buy | $31.00 | +181.05% | Reiterates | 5 months ago |
Applied Therapeutics IncAPLT | 6 | Hold | $1.50 | +7.91% | Reiterates | 5 months ago |
Karyopharm Therapeutics IncKPTI | 11 | Buy | $33.00 | +437.46% | Maintains | 5 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 7 | Buy | $58.00 | +226.94% | Maintains | 6 months ago |
Legend Biotech CorpLEGN | 1 | Buy | $84.00 | +161.60% | Reiterates | 6 months ago |
Gh Research PLCGHRS | 1 | Buy | $31.00 | +142.95% | Initiates Coverage On | 8 months ago |
Pliant Therapeutics IncPLRX | 13 | Hold | $3.00 | +65.75% | Maintains | 8 months ago |
Neumora Therapeutics IncNMRA | 6 | Hold | $4.00 | +133.92% | Reiterates | 8 months ago |
Axsome Therapeutics IncAXSM | 2 | Buy | $143.00 | +10.24% | Maintains | 9 months ago |
Newamsterdam Pharma Co NvNAMS | 1 | Buy | $40.00 | +14.29% | Reiterates | 9 months ago |
Intra Cellular Therapies IncITCI | 17 | Hold | $132.00 | +0.10% | Downgrades | 9 months ago |
Igm Biosciences IncIGMS | 15 | Hold | $1.50 | +18.11% | Downgrades | 9 months ago |
Hookipa Pharma IncHOOK | 11 | Hold | $2.00 | +127.01% | Downgrades | 10 months ago |
Sage Therapeutics IncSAGE | 19 | Hold | $4.00 | -53.92% | Upgrades | a year ago |
Marinus Pharmaceuticals IncMRNS | 8 | Hold | $1.00 | +81.82% | Maintains | a year ago |
Mind Medicine IncMNMD | 9 | Buy | $22.00 | N/A | Reiterates | a year ago |
Ambrx Biopharma IncAMAM | 3 | Buy | $32.00 | N/A | Maintains | 2 years ago |
Karuna Therapeutics IncKRTX | 7 | Buy | $225.00 | N/A | Maintains | 2 years ago |
Enanta Pharmaceuticals IncENTA | 14 | Hold | $15.00 | N/A | Maintains | 2 years ago |
Intercept Pharmaceuticals IncICPT | 11 | Hold | $19.00 | N/A | Maintains | 2 years ago |
Atai Life Sciences NvATAI | 3 | Hold | $9.00 | N/A | Maintains | 4 years ago |
Merus NvMRUS | 3 | Hold | $33.00 | N/A | Maintains | 4 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | $34.00 | N/A | Downgrades | 4 years ago |
Metacrine IncMTCR | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 5 years ago |
Neubase Therapeutics IncNBSE | 1 | Buy | $320.00 | N/A | Initiates Coverage On | 5 years ago |
Celgene CorpCELG | 2 | Buy | $118.00 | N/A | Downgrades | 7 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Epizyme IncEPZM | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 8 years ago |
Immune Design CorpIMDZ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 8 years ago |
Avexis IncAVXS | 1 | Hold | $92.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.